Alexion Pharmaceuticals, Inc. (ALXN) stock has gained 72.33% over the last 12 months, and the average rating from Wall Street analysts is a Hold. *InvestorsObserver’s* proprietary ranking system, gives ALXN stock a score of 82 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 90. ALXN's rank also includes a long-term technical score of 86. The fundamental score for ALXN is 69. In addition to the average rating from Wall Street analysts, ALXN stock has a mean target price of 166.846. This means analysts expect the stock to decline 10.83% over the next 12 months.
ALXN has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on ALXN!